The quest for groundbreaking treatments is driving rapid growth in the Oligonucleotide API Market. These specialized molecules are essential building blocks for developing new drug classes to combat a wide range of diseases. According to a recent analysis, the market is poised for significant expansion, with a projected Compound Annual Growth Rate (CAGR) of 5.60% …